scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Generation of magnetic fields over 20 T using a newly developed superconducting magnet system

Tsukasa Kiyoshi, +10 more
- 01 Mar 1993 - 
TL;DR: In this article, a newly developed superconducting magnet system at the National Research Institute for Metals accomplished generation of a magnetic field of 20.3 T in its clear bore of 44 mm in diameter.
Journal ArticleDOI

Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene–maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia–reperfusion injury

Jun Fang, +9 more
- 01 Apr 2010 - 
TL;DR: SMA-AHPP exerted a potent cytoprotective effect against I/R injury in rat liver, by inhibiting XO activity and the subsequent generation of O2 −, indicating the involvement of reactive oxygen species generated by XO.
Patent

Working substance for magnetic refrigeration and its production

Hideo Kimura, +3 more
TL;DR: In this paper, a working substance for magnetic refrigeration excellent in magnetic refrigerating performance by bringing a melt containing Gd, Tb, Dy, Ho and Er into contact with a Cu or Ag tape under specific conditions to undergo rapid cooling so as to be compounded integrally.
Journal ArticleDOI

Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.

Yasuhiro Yumoto, +11 more
- 01 Jan 1991 - 
TL;DR: The main side-effects of Lp-TAE combined with HT were low-grade fever, localized pain, myelo-suppression and liver dysfunction, but these were transient and eventually disappeared.
Journal ArticleDOI

Phosphorylcholine-Grafted Molecular Bottlebrush-Doxorubicin Conjugates: High Structural Stability, Long Circulation in Blood, and Efficient Anticancer Activity.

Shin Takano, +5 more
- 08 Mar 2021 - 
TL;DR: In this article, a poly(methacryloyloxyethyl phosphorylcholine) (pMPC)-grafted molecular bottlebrush (PCMB) was conjugated with a cancer drug, doxorubicin (DOX), via an acid-cleavable hydrazone bond.